|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 213/81 | (2006.01) |
| (11) | Number of the document | 3060550 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14799584.9 |
| Date of filing the European patent application | 2014-10-21 | |
| (97) | Date of publication of the European application | 2016-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-15 |
| (46) | Date of publication of the claims translation | 2019-08-12 |
| (86) | Number | PCT/US2014/061455 |
| Date | 2014-10-21 |
| (87) | Number | WO 2015/061247 |
| Date | 2015-04-30 |
| (30) | Number | Date | Country code |
| 201361893613 P | 2013-10-21 | US |
| (72) |
QIU, Hui, US
CALDWELL, Richard D., US
NEAGU, Constantin, US
MOCHALKIN, Igor, US
LIU-BUJALSKI, Lesley, US
JONES, Reinaldo, US
TATE, Devon, US
JOHNSON, Theresa L., US
GARDBERG, Anna, US
|
| (73) |
Merck Patent GmbH,
Frankfurter Strasse 250, 64293 Darmstadt,
DE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Heteroarilo junginiai, kaip BTK inhibitoriai, ir jų panaudojimas |
| HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2020-09-24 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-10-21 |